Source link : https://newshealth.biz/health-news/fda-approves-first-and-only-therapy-for-igg4-rd/
The US Food and Drug Administration (FDA) has approved the B-cell depleting agent inebilizumab-cdon (Uplizna, Amgen) for the treatment of immunoglobulin G4-related disease (IgG4-RD). This is the first and only treatment approved for this rare autoimmune disease in the United States. An estimated 200,000 people in the United States are living with IgG4-RD, according to […]
The post FDA Approves First and Only Therapy for IgG4-RD first appeared on News Health.
Author : News Health
Publish date : 2025-04-04 19:00:00
Copyright for syndicated content belongs to the linked Source.